Alnylam Pharma (ALNY) Tops Q4 EPS by 32c
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $239.56 -2.42%
EPS Growth %: -39.0%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -39.0%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q4 EPS of ($0.28), $0.32 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $24.02 million versus the consensus estimate of $13.1 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
